Publication | Closed Access
Age-related efficacy of the selective ß3-adrenoceptor agonist mirabegron for the treatment of overactive bladder (OAB): pooled analysis of three prospective, randomised Phase III studies in patients aged >= 65 years
10
Citations
0
References
2012
Year
No additional data available for this publication yet. Check back later!